Here we used a murine model of ALCL, driven by the expression of the human fusion oncogene NPM::ALK in T cells, to assess the effects of pharmacological inhibition or genetic deletion of specific class I HDAC isoforms. Here, ALK is linked to anaplastic large cell lymphoma.